The store will not work correctly when cookies are disabled.
(+/-)-6-(5-nitrobenzo[b]thiophen-2-yl)-5,6-dihydroimidazo[2,1-b]thiazole hydrochloride
ID: ALA3092293
PubChem CID: 72737030
Max Phase: Preclinical
Molecular Formula: C13H10ClN3O2S2
Molecular Weight: 303.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.O=[N+]([O-])c1ccc2sc(C3CN4C=CSC4=N3)cc2c1
Standard InChI: InChI=1S/C13H9N3O2S2.ClH/c17-16(18)9-1-2-11-8(5-9)6-12(20-11)10-7-15-3-4-19-13(15)14-10;/h1-6,10H,7H2;1H
Standard InChI Key: HSADHYVJNYYZJE-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
12.3446 -4.5362 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.7194 -5.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5125 -6.9469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0900 -5.6130 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5096 -5.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5151 -6.7003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3007 -5.8652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2057 -6.2761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0330 -6.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7237 -6.9466 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.5267 -5.6068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9363 -6.6965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0878 -6.9490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5773 -6.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2218 -5.4607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2288 -7.1080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3017 -6.6987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9349 -5.8719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7911 -5.4628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0800 -5.8769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7880 -4.6398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
10 8 1 0
6 16 2 0
15 5 2 0
12 18 2 0
11 7 2 0
17 7 1 0
9 8 1 0
14 13 2 0
18 15 1 0
3 9 1 0
14 4 1 0
4 7 1 0
2 18 1 0
3 17 1 0
8 2 2 0
9 11 1 0
12 10 1 0
16 12 1 0
13 17 1 0
19 20 2 0
19 21 1 0
5 19 1 0
M CHG 2 19 1 21 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.37 | Molecular Weight (Monoisotopic): 303.0136 | AlogP: 3.74 | #Rotatable Bonds: 2 |
Polar Surface Area: 58.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.10 | CX LogP: 3.25 | CX LogD: 3.25 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.63 | Np Likeness Score: -1.43 |
References
1. Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M.. (2013) Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests., 21 (24): [PMID:24183741] [10.1016/j.bmc.2013.09.053] |